Patient-Friendly Explanation

Peptide YY, or PYY, is a hormone your gut releases after you eat. It travels to your brain and tells it that you are full, helping you stop eating at the right time. In people with obesity, PYY levels are often lower than normal, which means the “fullness signal” is weaker — making it harder to feel satisfied after a meal and easier to overeat.

Clinical Definition

Peptide YY is a 36-amino-acid anorexigenic peptide co-secreted with GLP-1 from intestinal L-cells, primarily in the distal ileum and colon, in proportion to caloric intake. The active form, PYY3-36, is generated by dipeptidyl peptidase-4 (DPP-4) cleavage and acts as a high-affinity agonist at presynaptic Y2 receptors on NPY/AgRP neurons in the arcuate nucleus of the hypothalamus, suppressing appetite. Obese individuals exhibit blunted postprandial PYY responses, and exogenous PYY3-36 infusion has been shown to reduce food intake by approximately 30% in both lean and obese subjects.

Why It Matters

Understanding PYY helps explain why some weight-loss medications, particularly GLP-1 receptor agonists, are so effective — they enhance the body’s natural satiety signals. At NuLifeCare Singapore, we combine medical therapies that target these gut-brain pathways with nutritional strategies (high-protein, high-fibre meals) that naturally boost PYY secretion, creating a dual approach to appetite control.